[Facial ulcerated nodules revealing primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma].

Annales de dermatologie et de vénéréologie
M RollandH Adamski

Abstract

Primary cutaneous CD8+ aggressive, epidermotropic, cytotoxic T-cell lymphoma is a rare disease with a poor prognosis. Herein we report a new case, with facial lesions, which was difficult to diagnose. A 39-year-old woman was hospitalized for ulcerated nodules on the face that had been developing rapidly for 8 weeks. She had visited Djerba, Tunisia, 3 months earlier. No abnormalities were found on previous routine blood tests. Histopathological analysis of a skin biopsy had revealed non-specific lymphocytic infiltrate. Various therapies, including amoxicillin/clavulanic acid, valaciclovir, corticosteroids, colchicine and doxycycline, proved ineffective. Screening of the cutaneous sample for leishmaniasis proved positive using PCR but negative by direct examination and culture. Treatment was initiated with meglumine antimoniate. A further cutaneous biopsy revealed diffuse lymphocytic proliferation and led to a diagnosis of cutaneous CD8+ aggressive, epidermotropic, cytotoxic T-cell lymphoma. A PET scan showed multiple sites of hypermetabolism affecting the face and lymph nodes. Meglumine antimoniate was stopped and the patient experienced complete remission after chemotherapy. Ulcerated nodules with acute progression on acral sit...Continue Reading

References

Nov 6, 2004·Journal of Clinical Microbiology·Charles MaryHenri Dumon
Jun 28, 2006·Annales de dermatologie et de vénéréologie·E Poszepczynska-GuignéM Bagot
Dec 23, 2006·Annales de dermatologie et de vénéréologie·A Du-ThanhO Dereure
Jun 27, 2007·International Journal of Epidemiology·Afif Ben SalahPoulicos Prastacos
Jan 10, 2012·Journal of the American Academy of Dermatology·Ahmad NofalEman Salah
Jun 1, 2014·Surgical Pathology Clinics·Rein Willemze
May 11, 2016·Annales de dermatologie et de vénéréologie·E GardetteP Senet
Jan 28, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Joan GuitartYoun H Kim
Jul 6, 2017·Journal of the American Academy of Dermatology·Maria Estela Martinez-EscalaJoan Guitart
Dec 11, 2017·Clinical Lymphoma, Myeloma & Leukemia·Benoit M CyrenneFrancine Foss
May 3, 2018·Seminars in Cutaneous Medicine and Surgery·Yann Charli-JosephCarlos Ortiz-Hidalgo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
Daniel C MorseMadeleine Duvic
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Società Italiana Di Dermatologia E Sifilografia
Nicola DI MeoGiusto Trevisan
© 2022 Meta ULC. All rights reserved